BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27878904)

  • 1. Venous thromboembolism in patients with esophageal or gastric cancer undergoing neoadjuvant chemotherapy.
    Marshall-Webb M; Bright T; Price T; Thompson SK; Watson DI
    Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 27878904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism in oesophago-gastric carcinoma: incidence of symptomatic and asymptomatic events following chemotherapy and surgery.
    Rollins KE; Peters CJ; Safranek PM; Ford H; Baglin TP; Hardwick RH
    Eur J Surg Oncol; 2011 Dec; 37(12):1072-7. PubMed ID: 21925829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism during preoperative chemotherapy in the CRITICS gastric cancer trial.
    Slagter AE; Sikorska K; Grootscholten C; van Laarhoven HWM; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; van de Velde CJH; van Grieken NCT; van Sandick JW; Jansen EPM; Verheij M; Cats A
    Cancer Med; 2020 Sep; 9(18):6609-6616. PubMed ID: 32735752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors.
    Larsen AC; Frøkjær JB; Fisker RV; Iyer V; Mortensen PB; Yilmaz MK; Møller B; Kristensen SR; Thorlacius-Ussing O
    Thromb Res; 2015 May; 135(5):802-8. PubMed ID: 25743885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in patients receiving perioperative chemotherapy for esophagogastric cancer.
    Khanna A; Reece-Smith AM; Cunnell M; Madhusudan S; Thomas A; Bowrey DJ; Parsons SL
    Dis Esophagus; 2014 Apr; 27(3):242-7. PubMed ID: 23651074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of venous thromboembolism after surgery for esophagogastric malignancy and the impact of chemotherapy: a population-based cohort study.
    Adiamah A; Ban L; West J; Humes DJ
    Dis Esophagus; 2020 Jun; 33(6):. PubMed ID: 31617892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of venous thromboembolism in ovarian cancer patients receiving neoadjuvant chemotherapy.
    Basaran D; Boerner T; Suhner J; Sassine D; Liu Y; Grisham RN; Tew WP; Gardner GJ; Zivanovic O; Sonoda Y; Long Roche K; Chi DS; Abu-Rustum NR; Soff GA; Jewell EL
    Gynecol Oncol; 2021 Oct; 163(1):36-40. PubMed ID: 34312001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer.
    Chavan DM; Huang Z; Song K; Parimi LRH; Yang XS; Zhang X; Liu P; Jiang J; Zhang Y; Kong B; Li L
    Medicine (Baltimore); 2017 Oct; 96(42):e7935. PubMed ID: 29049188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venous thromboembolism in cancer patients receiving neoadjuvant chemotherapy: a systematic review and meta-analysis.
    Di Nisio M; Candeloro M; Rutjes AWS; Porreca E
    J Thromb Haemost; 2018 Jul; 16(7):1336-1346. PubMed ID: 29754426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Venous Thromboembolism for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Preoperative Chemotherapy Followed by Surgical Resection.
    Boone BA; Zenati MS; Rieser C; Hamad A; Al-Abbas A; Zureikat AH; Hogg ME; Neal MD; Zeh HJ
    Ann Surg Oncol; 2019 May; 26(5):1503-1511. PubMed ID: 30652227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and risk of venous thromboembolism according to primary treatment in women with ovarian cancer: A retrospective cohort study.
    Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Yoon SH; Kim YB
    PLoS One; 2021; 16(4):e0250723. PubMed ID: 33909674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of thromboembolic complications in patients with esophagogatric adenocarcinoma undergoing preoperative chemotherapy.
    Papaxoinis G; Kamposioras K; Germetaki T; Weaver JMJ; Stamatopoulou S; Nasralla M; Kordatou Z; Owen-Holt V; Anthoney A; Mansoor W
    Acta Oncol; 2018 Jun; 57(6):790-798. PubMed ID: 29308947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer.
    Salinaro JR; McQuillen K; Stemple M; Boccaccio R; Ehrisman J; Lorenzo AM; Havrilesky L; Secord AA; Galvan Turner V; Moore KN; Davidson B
    Int J Gynecol Cancer; 2020 Apr; 30(4):491-497. PubMed ID: 32054646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer.
    Guadagni F; Riondino S; Formica V; Del Monte G; Morelli AM; Lucchetti J; Spila A; D'Alessandro R; Della-Morte D; Ferroni P; Roselli M
    World J Gastroenterol; 2017 Jul; 23(28):5187-5195. PubMed ID: 28811713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of and risk factors for venous thromboembolism during surgical treatment for esophageal cancer: a single-institution study.
    Kato F; Takeuchi H; Matsuda S; Kawakubo H; Omori T; Kitagawa Y
    Surg Today; 2016 Apr; 46(4):445-52. PubMed ID: 26094966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer.
    Chokshi SK; Gaughan JP; Krill L
    J Thromb Thrombolysis; 2022 Jan; 53(1):202-207. PubMed ID: 34185227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
    Khorana AA; Dalal M; Lin J; Connolly GC
    Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism risk in patients receiving neoadjuvant chemotherapy for bladder cancer.
    Garas SN; McAlpine K; Ross J; Carrier M; Bossé D; Yachnin D; Mallick R; Cagiannos I; Morash C; Breau RH; Lavallée LT
    Urol Oncol; 2022 Aug; 40(8):381.e1-381.e7. PubMed ID: 35581123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Risk Factors Related to Symptomatic Venous Thromboembolic Events After Esophagectomy for Cancer.
    Mantziari S; Gronnier C; Pasquer A; Gagnière J; Théreaux J; Demartines N; Schäfer M; Mariette C;
    Ann Thorac Surg; 2016 Sep; 102(3):979-984. PubMed ID: 27262916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Timing of Thromboembolic Events in Patients With Ovarian Cancer Undergoing Neoadjuvant Chemotherapy.
    Greco PS; Bazzi AA; McLean K; Reynolds RK; Spencer RJ; Johnston CM; Liu JR; Uppal S
    Obstet Gynecol; 2017 Jun; 129(6):979-985. PubMed ID: 28486358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.